Table 5.
Comparing excretion rates of various proteins and cadmium in the high-exposure group stratified by eGFR levels.
Parameters | All Subjects n = 215 |
eGFR a, mL/min/1.73 m2 | p | ||
---|---|---|---|---|---|
>90, n = 33 | 61–90, n = 131 | ≤60, n = 51 | |||
Age, years | 57.0 ± 11.1 | 49.4 ± 9.4 | 55.6 ± 9.6 | 65.6 ± 10.6 | <0.001 |
BMI, kg/m2 | 21.4 ± 3.6 | 21.2 ± 3.2 | 21.3 ± 3.5 | 21.7 ± 4.3 | 0.822 |
eGFR, mL/min/1.73 m2 | 71.6 ± 19.4 | 100.4 ± 8.3 | 74.6 ± 8.2 | 45.4 ± 11.3 | <0.001 |
Plasma creatinine, mg/dL | 1.07 ± 0.35 | 0.79 ± 0.13 | 0.98 ± 0.14 | 1.50 ± 0.44 | <0.001 |
Urine creatinine, mg/dL | 118.4 ± 62.2 | 99.1 ± 53.1 | 116.8 ± 60.2 | 135.2 ± 69.4 | 0.054 |
Plasma to urine creatinine ratio | 0.0125 ± 0.0096 | 0.0116 ± 0.0097 | 0.0118 ± 0.0094 | 0.0148 ± 0.0098 | 0.034 |
Urine Cd, µg/L | 11.85 ± 12.28 | 11.18 ± 18.70 | 10.56 ± 8.05 | 15.61 ± 15.31 | 0.079 |
Urine β2M, mg/L | 4.92 ± 17.43 | 0.20 ± 0.36 | 1.18 ± 4.02 | 17.57 ± 32.31 | <0.001 |
Urine α1M, mg/L | 13.09 ± 18.68 | 5.66 ± 6.17 | 8.37 ± 7.91 | 30.04 ± 30.31 | <0.001 |
Urine albumin, mg/L | 25.57 ± 70.59 | 7.62 ± 7.29 | 22.64 ± 76.57 | 44.72 ± 73.74 | <0.001 |
Urine protein, mg/L | 85.4 ± 199.1 | 14.9 ± 22.6 | 56.2 ± 144.6 | 206.2 ± 307.7 | <0.001 |
Normalized to Ecr as Ex/Ecr b | |||||
ECd/Ecr, µg/g creatinine | 10.43 ± 8.02 | 10.26 ± 10.35 | 9.98 ± 6.79 | 11.69 ± 9.20 | 0.641 |
Eβ2M/Ecr, mg/g creatinine | 4.87 ± 16.55 | 0.23 ± 0.37 | 1.66 ± 9.72 | 16.13 ± 27.49 | <0.001 |
Eα1M/Ecr, mg/g creatinine | 11.34 ± 15.00 | 5.78 ± 4.95 | 7.53 ± 6.30 | 24.72 ± 24.57 | <0.001 |
EAlb/Ecr, mg/g creatinine | 23.21 ± 55.07 | 10.47 ± 15.68 | 20.71 ± 59.50 | 37.88 ± 57.23 | <0.001 |
EProt/Ecr, mg/g creatinine | 78.25 ± 174.96 | 16.73 ± 24.54 | 57.98 ± 149.26 | 170.13 ± 246.01 | <0.001 |
Eβ2M/Ecr, µg/g creatinine (%) | |||||
<100 | 36.7 | 51.5 | 43.5 | 9.8 | <0.001 |
100–999 | 37.7 | 42.4 | 42.0 | 23.5 | <0.001 |
1000 | 25.6 | 6.1 | 14.5 | 66.7 | <0.001 |
EAlb/Ecr, mg/g creatinine (%) | |||||
<30 | 84.2 | 93.9 | 88.5 | 66.7 | <0.001 |
30–300 | 15.3 | 0.1 | 10.7 | 33.3 | <0.001 |
>300 | 0.5 | 0 | 0.8 | 0 | 0.017 |
Normalized to Ccr as Ex/Ccr c | |||||
(ECd/Ccr) × 100, µg/L filtrate | 11.27 ± 9.89 | 8.10 ± 9.06 | 9.67 ± 6.60 | 17.44 ± 14.17 | <0.001 |
(Eβ2M/Ccr) × 100, mg/L filtrate | 7.74 ± 29.06 | 0.18 ± 0.28 | 1.82 ± 11.58 | 27.82 ± 52.20 | <0.001 |
(Eα1M/Ccr) × 100, mg/L filtrate | 15.00 ± 28.25 | 4.46 ± 3.59 | 7.45 ± 6.63 | 41.20 ± 48.68 | <0.001 |
(EAlb/Ccr) × 100, mg/L filtrate | 29.06 ± 75.93 | 7.50 ± 9.83 | 20.23 ± 56.82 | 65.68 ± 119.75 | <0.001 |
(EProt/Ccr) × 100, mg/L filtrate | 109.9 ± 316.8 | 13.0 ± 19.1 | 56.3 ± 141.0 | 310.2 ± 568.2 | <0.001 |
n, number of subjects; eGFR, estimated glomerular filtration rate; Ex, excretion of x; cr, creatinine; Ccr, creatinine clearance; Prot, protein; Cd, cadmium; a eGFR was determined by equations of the Chronic Kidney Disease Epidemiology Collaboration [20]. b Ex/Ecr = [x]u/[cr]u; c Ex/Ccr = [x]u[cr]p/[cr]u, where x = Prot or Cd [25]. Data for all continuous variables are arithmetic means ± standard deviation (SD). For all tests, p ≤ 0.05 identifies statistical significance, determined by Kruskal–Wallis test for mean differences across three eGFR ranges.